Atsuki Kume
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care.
Journal: Current eye research
Published: April 12, 2021
Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus.
Journal: BMC ophthalmology
Published: April 09, 2020
Recent Epidemiological Status of Ocular and Other Major Complications Related to Diabetes Mellitus in Japan.
Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
Published: January 08, 2019
CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: December 22, 2016
Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration.
Journal: Scientific reports
Published: August 25, 2016
Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular Degeneration.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: May 24, 2016
Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: March 22, 2016
Treatment Patterns and Health Care Costs for Age-Related Macular Degeneration in Japan: An Analysis of National Insurance Claims Data.
Journal: Ophthalmology
Published: October 28, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026